Several numbers of lawsuits have been filed against manufacturers (GlaxoSmithKline) of Zofran over the safety of the drug. There are numbers of U.S families who are suffering from the severe Birth defect cause by Zofran. The FDA approved Zofran in 1991 as a drug to treat nausea and vomiting, but only in patients who have undergone chemotherapy or radiotherapy, or who are experiencing nausea after surgery. The medication has never been approved for the treatment of morning sickness in pregnant women. However, doctors are still prescribing Zofran to pregnant women as “off-label because they believe the chances of birth defects is rare. Zofran has been linked to an increased risk of heart defects, cleft palate, and other devastating Zofran birth defects. Acquiring compensation from the Zofran class-action lawsuit isn’t as important to any mother as revealing the dangerous consequence of the drug to the Public.
A woman from Illinois recently filed a lawsuit against Zofran manufacturer. According to her lawsuit the woman claims that Zofran medication forced her to terminate a 2014 pregnancy due to severe physical malformations of her unborn child. In her court document she stated that she became pregnant in 2014 and in the first trimester of her pregnancy she was prescribed Zofran medication to treat morning sickness. Zofran works by reducing the effects of a naturally-occurring chemical in the body called serotonin, which causes nausea and vomiting. The fetal development in the initial stage of pregnancy is very delicate. In July of that year she was diagnosed with a test which reveals that her unborn child had developed congenital malformations, including severe and life-threatening abdominal defects. In August 2014 she had terminated her pregnancy.
The woman’s Zofran lawsuit was filed on July 25, 2016 in the US District Court of Massachusetts under the case number 1:16-CV-11536-FDS. More than 250 similar lawsuits have been consolidated in the Boston federal court. The plaintiff lawsuit joins those lawsuits which are pending in Boston federal court. There are several studies which clarify that Zofran exposure in pregnancy cause life-threatening birth defects. The plaintiffs allege similar allegations that GlaxoSmithKline’s failure to adequately warn about the potential Zofran side effects on unborn babies. Drug labels do not include warnings about the risk of Zofran birth defects, the manufacturers are responsible for ignoring, manufacturing, selling and marketing a drug without disclosing its risks.
According to court documents, the government filed a claim against Glaxo after it engaged in promoting off-label use of several drugs, including Zofran. The manufacturer admitted that using Zofran for nausea and vomiting in pregnant women has not been tested. However it does not stop them from promoting off-label use of the drug. The manufacturer withheld mounting evidence of the drug’s potential to harm developing babies from doctors, patients and the general public. If you or somebody you know had a baby with a birth defect after taking Zofran during pregnancy, you should contact Drugsclaim.com for free case review. We have an experience attorneys group who evaluate your case free of cost unless we win the case for you.